Public Company News

Radiopharm Theranostics has appointed Rama Abu Shmeis as Senior Vice President Chemistry, Manufacturing and Controls, or “CMC” as the latest in a line of top-shelf appointments. The ASX-listed cancer fighter says Dr Shmeis brings a 23-year record of achievements in leading strategic, operational and scientific aspects of CMC development and manufacturing that also covers a wide variety of dose forms, products and technologies.

Everest Metals Corporation has hailed a new agreement to earn up to 100 per cent in the advanced Revere gold project north-east of Meekatharra in WA as a transformational opportunity for the company. Everest, formally known as Twenty Seven Co pointed to the zone’s historical production, significant gold-copper potential and clear runway to establishing a JORC compliant resource as key merits in the acquisition.

New assays from RC drilling at Surefire Resources' Victory Bore deposit in WA’s Mid West have delivered extensive vanadium mineralisation the company says could rate it amongst the country’s best. The work follows the discovery of three parallel mineralised lodes including broad intercepts of up to 56m at 0.48 per cent vanadium oxide with Surefire looking to build on the site's already monstrous 151 million tonne resource.

CZR Resources is a step closer to production at its Robe Mesa iron ore project after receiving mining approval from the Department of Mines, Industry Regulation and Safety for two of the site’s key deposits. The approval has been granted for the company’s Robe Mesa and P529 deposits that respectively sit north and south of Rio Tinto’s Mesa F project around 120km from Karratha in the Pilbara region of WA.

ASX-listed Neometals’ joint venture Primobius has expanded a technology and battery recycling JV option agreement with leading steel producer Stelco Holdings to allow it time to buy into its lithium-ion battery special purpose vehicle. The amendment follows a 2021 agreement for the duo to establish a long-term commercial recycling relationship in North America – one of the fastest growing sectors in terms of lithium-ion battery production.

Strickland Metals is pressing ahead with plans to spinoff its base metals assets into a new company to seek better value for the projects whilst focusing on its prospective gold package in central WA. The company has also gained heritage clearance to drill at its Iroquois project, which along with its Bryah Basin assets will be the centerpiece of the new operation.

Lindian Resources has received its first assays from the company’s maiden campaign at its Kangankunde project in Malawi showing continuous rare earths mineralisation from surface across the length of both holes. Assay highlights include a 1m section recording an outstanding 11.8 per cent total rare earth oxide, or “TREO” from 13m with a second 1m section going 11.1 per cent TREO from 12m.

ASX listed Estrella Resources has completed the mining and crushing phase of its nickel sulphide extraction program using ore from its 5A nickel mine near Kambalda in WA. The company plans to treat the high-grade material at Glencore’s Murrin Murrin facility after sealing an offtake and processing agreement late last year.

ASX-listed Okapi Resources has reinforced its uranium footprint in the United States after securing full ownership of 45 new mining claims and one State Mineral lease in Colorado. The acquisition stretches the boundaries of the company’s Maybell uranium project where historical production tipped the scales at 5.3 million pounds of triuranium octoxide running a solid average grade of 1300 parts per million.

Neometals has extended a deal with Scandinavian battery metals firm Critical Metals until the end of February to give the company time to secure an increased vanadium source deal using by-product from Nordic steelmaker SSAB. A joint venture between Neometals and Critical Metals on its proposed vanadium recovery project is also progressing.

Meeka Metals has expanded the mineral resource at its Murchison gold project in outback WA to 1.2m ounces on the back of a 12 per cent increase to its Turnberry deposit in the historic gold-bearing region. The company is putting the finishing touches on a prefeasibility study with an eye to join several players mining in the region.

Radiopharm Theranostics has been given the keys to the United States outpatient clinics to begin imaging trials of patients with pancreatic cancer after receiving the tick of approval from the US Food and Drug Administration for its cancer-seeking peptide.The USFDA has granted Radiopharm investigational new drug approval which will allow the company to test its patented RAD301 integrin technology in the real world.